Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
131.87
-3.47 (-2.56%)
Nov 10, 2026, 10:44 AM EST - Market open
Twist Bioscience Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Twist Bioscience stock has a consensus rating of "Buy" and an average price target of $168.25. The average 1-year stock price forecast is 27.59% higher than the current stock price, while the lowest is $45 (-65.88%) and the highest is $215 (+63.04%).
Price Target: $168.25 (+27.59%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Twist Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 11 | 11 | 11 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates $115 → $190 | Buy | Reiterates | $115 → $190 | +44.08% | Oct 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $120 → $205 | Buy | Maintains | $120 → $205 | +55.46% | Oct 12, 2026 |
| Jefferies | Jefferies | Hold Initiates $150 | Hold | Initiates | $150 | +13.75% | Oct 8, 2026 |
| Barclays | Barclays | Buy Maintains $112 → $215 | Buy | Maintains | $112 → $215 | +63.04% | Oct 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $107 → $212 | Buy | Maintains | $107 → $212 | +60.76% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
456.27M
from 376.57M
Increased by 21.16%
Revenue Next Year
548.67M
from 456.27M
Increased by 20.25%
EPS This Year
-1.20
from -2.12
EPS Next Year
-0.40
from -1.20
EPS and Forward PE are based on non-GAAP adjusted numbers.